| |
| |
|
| Insider
Information: |
Aliski William |
| Relationship: |
Director |
| City: |
Novato |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
118,516 |
|
|
Indirect Shares
|
80,806 |
|
|
| Direct
Value |
$3,017,592 |
|
|
|
Indirect Value
|
$3,574,857 |
|
|
| Total
Shares |
199,322 |
|
|
| Total
Value |
$6,592,449 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
4
|
|
Stock
price went up :
|
0
|
3
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
3.0
|
| Percentage
Gain/Loss : |
0.0%
|
 306.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ultragenyx Pharmaceutical Inc |
RARE |
Director |
2021-06-24 |
66,849 |
2021-06-24 |
80,806 |
Premium* |
|
|
Applied Genetic Technologies Corp |
AGTC |
Director |
2022-11-30 |
0 |
2018-12-14 |
0 |
Premium* |
|
|
X4 Pharmaceuticals Inc |
XFOR |
Director |
2023-06-13 |
51,667 |
2022-06-06 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| XFOR |
X4 Pharmaceuticals Inc |
Director |
– • – |
2023-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
45,000 |
51,667 |
0 |
- |
|
| AGTC |
Applied Genetic Technolog... |
Director |
– • – |
2022-11-30 |
4 |
D |
$0.00 |
$0 |
D/D |
(8,500) |
0 |
0 |
- |
|
| XFOR |
X4 Pharmaceuticals Inc |
Director |
– • – |
2022-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
6,667 |
6,667 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
Director |
– • – |
2021-06-24 |
4 |
A |
$0.00 |
$0 |
D/D |
2,145 |
66,849 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
Director |
– • – |
2021-02-23 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,000 |
64,704 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
Director |
– • – |
2021-02-19 |
4 |
S |
$149.01 |
$1,117,575 |
D/D |
(7,500) |
65,704 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
Director |
– • – |
2021-02-19 |
4 |
OE |
$97.85 |
$733,875 |
D/D |
7,500 |
73,204 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
Director |
– • – |
2020-08-21 |
4 |
OE |
$58.74 |
$293,700 |
D/D |
5,000 |
62,018 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
Director |
– • – |
2020-08-21 |
4 |
S |
$86.57 |
$432,850 |
D/D |
(5,000) |
57,018 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
Director |
– • – |
2020-05-18 |
4 |
S |
$74.02 |
$1,480,322 |
I/I |
(20,000) |
70,350 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
Director |
– • – |
2020-05-18 |
4 |
S |
$74.65 |
$559,875 |
D/D |
(7,500) |
47,924 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
Director |
– • – |
2020-05-18 |
4 |
OE |
$40.37 |
$302,775 |
D/D |
7,500 |
55,424 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
Director |
– • – |
2019-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
47,924 |
0 |
- |
|
| AGTC |
Applied Genetic Technolog... |
Director |
– • – |
2018-12-14 |
4 |
B |
$3.24 |
$19,477 |
D/D |
6,000 |
8,500 |
2.39 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
Director |
– • – |
2018-12-07 |
4 |
AS |
$49.69 |
$298,140 |
I/I |
(6,000) |
90,350 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
Director |
– • – |
2018-11-08 |
4 |
AS |
$55.67 |
$334,020 |
I/I |
(6,000) |
96,350 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
Director |
– • – |
2018-10-08 |
4 |
AS |
$73.38 |
$440,280 |
I/I |
(6,000) |
102,350 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
Director |
– • – |
2018-08-08 |
4 |
S |
$76.66 |
$287,475 |
D/D |
(3,750) |
72,610 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
Director |
– • – |
2018-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
76,360 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
Director |
– • – |
2018-04-19 |
4 |
AS |
$53.97 |
$35,081 |
I/I |
(650) |
108,350 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
Director |
– • – |
2018-01-23 |
4 |
OE |
$21.00 |
$241,500 |
D/D |
11,500 |
73,360 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
Director |
– • – |
2017-06-22 |
4 |
A |
$0.00 |
$0 |
D/D |
1,875 |
61,860 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
|
– • – |
2016-12-05 |
4 |
S |
$77.94 |
$469,160 |
D/D |
(6,000) |
59,985 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
|
– • – |
2016-12-05 |
4 |
OE |
$21.00 |
$126,000 |
D/D |
6,000 |
65,985 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
|
– • – |
2016-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,875 |
59,985 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
